Richard H. Ebright, Ph.D., is Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University and Laboratory Director at the Waksman Institute of Microbiology. His research focusses on the structure, mechanism, and regulation of bacterial transcription complexes, and on the development of inhibitors of bacterial transcription as antituberculosis agents and broad-spectrum antibacterial agents. His research employs tools of structural biology, biophysics, and drug-discovery. He received his AB (Biology, summa cum laude) and Ph.D.
(Microbiology and Molecular Genetics) degrees from Harvard University. He performed graduate research at Harvard and the Institut Pasteur and was a Junior Fellow of the Harvard University Society of Fellows. In 1987, he was appointed as a Laboratory Director at the Waksman Institute and a faculty member at Rutgers University. From 1997 to 2013, he was co-appointed as an Investigator of the Howard Hughes Medical Institute. He has received the Searle Scholar Award, the Schering-Plough Award of the American Society for Biochemistry and Molecular Biology, the Walter J. Johnson Prize, and the National Institutes of Health MERIT Award. He is a Fellow of the American Academy of Arts and Sciences, the American Association for Advancement of Science, the American Academy of Microbiology, and the Infectious Diseases Society of America.
Richard H. Edbright's labpage